eHealth, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by eHealth, Inc. on September 19, 2021. The report discloses the appointment of a new Chief Financial Officer and the associated compensatory arrangements.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation details:
- Base Salary: $450,000 annually.
- Target Bonus: 75% of annual base salary (prorated for 2021).
- Initial Equity Grants: Approximately $1,000,000 in time-based restricted stock units (RSUs) and $1,000,000 in performance-based RSUs.
- Future Equity Grants: Approximately $1,000,000 in equity awards scheduled for 2022.
Material Changes
The primary material change is the appointment of Christine Janofsky as Senior Vice President and Chief Financial Officer, effective September 20, 2021. She replaces John Pierantoni as the principal financial officer, though Mr. Pierantoni will continue to serve as the principal accounting officer.
Management Commentary, Risks, and Contingencies
The filing outlines specific severance contingencies for Ms. Janofsky:
- Termination Without Cause/Good Reason: Entitles the executive to 12 months of base salary and 12 months of health benefits.
- Change in Control: If termination occurs within 12 months of a change in control, the executive receives 100% of the target annual cash bonus and 100% vesting of outstanding time-based equity awards.
The filing states there are no family relationships requiring disclosure and no other undisclosed transactions between the executive and the company.
Investor Verification Checklist
- Verify the vesting schedule and specific performance targets for the $1,000,000 performance-based RSU grant.
- Confirm the exact share count for all equity awards once calculated by the Compensation Committee based on the trailing 30-day average share price.
- Review the full text of the Severance Agreement when filed as an exhibit to the Form 10-Q for the quarter ended September 30, 2021.
- Monitor future filings for the 2022 Equity Awards terms and vesting schedule.